Ld Path Group: Source BioScience completes 18.5m strategic acquisition of LDPath Ltd to reimagine the future of pathology by combining cellular and digital pathology platforms

SourceBio International plc, a leading international provider of integrated state-of-the-art laboratory services and products, announces that it has agreed to purchase the entire issued capital of LDPath Limited ("LDP"), a London based leader in Digital Pathology testing services. SourceBio International plc, a leading international provider of integrated state-of-the-art laboratory services and products, announces that it has agreed to purchase the entire issued capital of LDPath Limited ("LDP"), a London based leader in Digital Pathology testing services.